30 December 2011
Early steroid withdrawal – impact on diabetes mellitus and kidney function in heart transplant recipients
Maria K. LizakABCDEF, Michał ZakliczyńskiE, Anna JaroszB, Marian ZembalaE, Zbigniew KalarusEAnn Transplant 2011; 16(4): 92-98 :: ID: 882224
Abstract
Background: The aim of this study was to assess the effect of early steroid withdrawal on renal function, diabetes mellitus (DM) and coronary artery vasculopathy of the transplanted heart (CAV) development and late rejection in orthotopic heart transplant (OHT) recipients.
Material/Methods: 76 patients undergoing OHT in years 2000–2004 (6 women, 50% ischemic, 49±7 years, BMI 24±3.6, glomerular filtration ratio (GFR) – 68–20 ml/kg/min, LVEF 57±6%) receiving maintenance immunosuppression (cyclosporine, prednisone and azathioprine or mycophenolate mofetil) were observed for 5 years in groups, depending on steroid withdrawal time: Group 1 (N=48) – withdrawal later than 12 months post-OHT, Group 2 (N=28) – withdrawal up to 12 months post-OHT. Number of serious rejection episodes (SRE >ISHLT grade 2), time to first SRE after steroid withdrawal (TTSRE), need for steroid reinforcement, CAV presence, need for percutaneous coronary intervention (PCI), DM and abnormal GFR were compared between groups. P<0.05 was significant.
Results: Steroids were administered for 615±188 days in group 1 (G1) and 309±96 days in group 2 (G2). There was a difference between group 1 and 2 in the number of SREs before 12 months (2.4±1.6 vs. 1.6±1.3) and before steroid withdrawal (2.4±1.6 vs. 1.5±1.3), but not in number (0.15±0.62 vs. 0.14±0.36) and percent of patients with an SRE (8.3 vs. 14.3%) after steroid withdrawal. There was no difference in TTSRE (314±312 vs. 199±122 days), need for steroid reinforcement (6.3 vs. 14.3%), time from steroid withdrawal to reinforcement (377±317 vs. 246±130 days), CAV (8.3 vs. 3.6%), PCI (4.2 vs. 3.6%), GFR 60–90 ml/kg/min (30.8 vs. 20.0%), and GFR <60 ml/kg/min (64.1 vs. 80.0%) at 5 years. DM was diagnosed in 58.3 and 71.4% of patients at discharge (p=NS) and in 51.3 and 80% at 5 years in group 1 and 2, respectively (p=0.018).
Conclusions: Patients with earlier steroid withdrawal presented DM and tended to present more severe stages of kidney failure more often. Despite lower frequency of CAV, they tended to require PCI equally often.
Keywords: Diabetes mellitus, Kidney Failure, kidney function, heart trans, Heart Transplantation, prognosis, Steroids
In Press
Original article
Common Versus External Iliac Arterial Anastomosis in Kidney Transplantation: A Bicentric Retrospective Anal...Ann Transplant In Press; DOI: 10.12659/AOT.953269
Original article
Protective Effects of Quercetin and Sucrose on Cold Preservation Injury in Porcine Kidneys Donated After Ca...Ann Transplant In Press; DOI: 10.12659/AOT.952503
Original article
Four Years of Clinical Experience With COVID-19 Outcomes in Heart Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952888
Original article
Determinants of Lack of Consent for Deceased Organ Donation Among Nurses and Physicians: A Cross-Sectional ...Ann Transplant In Press; DOI: 10.12659/AOT.953598
Most Viewed Current Articles
24 Aug 2021 : Review article 21,160
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 17,335
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,325
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,249
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






